SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000078003-23-000011
Filing Date
2023-02-13
Accepted
2023-02-13 17:06:33
Documents
2
Group Members
ANACOR PHARMACEUTICALS, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G AN2 THERAPEUTICS an2therapeuticsinc_13gx2x2.htm SC 13G 67185
2 EX-99.1 JOINT FILING AGREEMENT exhibit99_an2.htm EX-99.1 6561
  Complete submission text file 0000078003-23-000011.txt   75379
Mailing Address 235 E 42ND ST NEW YORK NY 10017
Business Address 235 E 42ND ST NEW YORK NY 10017 2125732323
PFIZER INC (Filed by) CIK: 0000078003 (see all company filings)

IRS No.: 135315170 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1800 EL CAMINO REAL, SUITE D MENLO PARK CA 94027
Business Address 1800 EL CAMINO REAL, SUITE D MENLO PARK CA 94027 (650) 331-9090
AN2 Therapeutics, Inc. (Subject) CIK: 0001880438 (see all company filings)

IRS No.: 820606654 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-93617 | Film No.: 23619743
SIC: 2834 Pharmaceutical Preparations